Skip to navigation menu Skip to content
Clinical Trial Search block Test

A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE III TRIAL TO ASSESS THE SAFETY AND EFFICACY OF VIASKIN® PEANUT IN PEANUT-ALLERGIC YOUNG CHILDREN 1-3 YEARS OF AGE

Epitope

What is the goal of the study?

To learn more about this study, please email the study team member listed below.

Who can participate in the study?

Everyone

Study Team: